We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+4.63%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+377.38%
AUM
$921M
AUM Growth
-$85.5M
Cap. Flow
-$110M
Cap. Flow %
-11.98%
Top 10 Hldgs %
14.09%
Holding
5,143
New
1,384
Increased
1,284
Reduced
1,171
Closed
1,233

Sector Composition

Rank Sector Weight
1 Financials 13.75%
2 Technology 8.29%
3 Industrials 7.33%
4 Healthcare 6.94%
5 Consumer Discretionary 6.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EHC icon
1051
Encompass Health
EHC
$11B
$87K 0.01%
2,665
+1,252
+89% +$40.6K
MYGN icon
1052
Myriad Genetics
MYGN
$301M
$87K 0.01%
+5,174
New +$93.6K
ITCI
1053
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$87K 0.01%
5,762
+3,382
+142% +$47.8K
HIBB
1054
DELISTED
Hibbett, Inc. Common Stock
HIBB
$87K 0.01%
2,327
+2,285
+5,440% +$92.6K
ABCB icon
1055
Ameris Bancorp
ABCB
$5.97B
$86K 0.01%
1,975
+1,909
+2,892% +$77.6K
AXTI icon
1056
AXT Inc
AXTI
$4.49B
$86K 0.01%
17,974
+15,836
+741% +$81.6K
FSLR icon
1057
First Solar
FSLR
$25.4B
$86K 0.01%
2,684
-226
-8% -$7.93K
GT icon
1058
Goodyear
GT
$1.99B
$86K 0.01%
2,804
+1,224
+77% +$37.9K
ORI icon
1059
Old Republic International
ORI
$10.5B
$86K 0.01%
4,550
-4,830
-51% -$86.9K
PSMT icon
1060
Pricesmart
PSMT
$5.76B
$86K 0.01%
+1,025
New +$90.1K
ACM icon
1061
Aecom
ACM
$9.63B
$85K 0.01%
2,334
-9,558
-80% -$317K
CMC icon
1062
Commercial Metals
CMC
$8.37B
$85K 0.01%
3,896
-17,802
-82% -$349K
ELME
1063
Elme Communities
ELME
$146M
$85K 0.01%
+2,595
New +$79.2K
UFS
1064
DELISTED
DOMTAR CORPORATION (New)
UFS
$85K 0.01%
2,162
+984
+84% +$37.5K
ASPS icon
1065
Altisource Portfolio Solutions
ASPS
$63.8M
$84K 0.01%
395
+15
+4% +$3.35K
LXFR icon
1066
Luxfer Holdings
LXFR
$458M
$84K 0.01%
+7,692
New +$81.4K
CDK
1067
DELISTED
CDK Global, Inc.
CDK
$84K 0.01%
1,406
-6,676
-83% -$382K
TIVO
1068
DELISTED
Tivo Inc
TIVO
$84K 0.01%
4,025
-2,355
-37% -$47.9K
FIVE icon
1069
Five Below
FIVE
$12.4B
$83K 0.01%
+2,082
New +$82K
TEVA icon
1070
Teva Pharmaceuticals
TEVA
$40.5B
$83K 0.01%
2,281
-5,216
-70% -$208K
QTS
1071
DELISTED
QTS REALTY TRUST, INC.
QTS
$83K 0.01%
1,680
+1,580
+1,580% +$76.3K
RATE
1072
DELISTED
Bankrate Inc
RATE
$83K 0.01%
+7,449
New +$70.5K
FET icon
1073
Forum Energy Technologies
FET
$849M
$82K 0.01%
187
+183
+4,575% +$76.5K
SPXL icon
1074
Direxion Daily S&P 500 Bull 3x ETF
SPXL
$7.34B
$82K 0.01%
3,048
-253,092
-99% -$6.32M
TGNA
1075
DELISTED
TEGNA Inc
TGNA
$82K 0.01%
+5,969
New +$81.2K

Similar funds

Tower Research Capital (TRC)'s Q4 2016 Portfolio in Review

As of Q4 2016, Tower Research Capital (TRC) held 5,143 positions worth $921M, down 8.5% from $1.01B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Tower Research Capital (TRC) withdrew a net $110M in Q4 2016, closing 1,233 positions and reducing 1,171 holdings. Its most notable exit was Vanguard Real Estate ETF, an estimated $18.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 3.3% a quarter earlier, followed by Technology and Industrials.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Biotechnology ETF worth $9.93M.

  • Tower Research Capital (TRC)'s largest Q4 2016 buy was iShares Biotechnology ETF: 112,296 shares worth $9.93M.
  • Tower Research Capital (TRC) added most to Microsoft in Q4 2016, an estimated $11.2M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $265M.
  • Tower Research Capital (TRC) fully exited Vanguard Real Estate ETF in Q4 2016, selling an estimated $18.2M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 14% of its $921M portfolio in Q4 2016.
  • Tower Research Capital (TRC) opened 1,384 new positions and closed 1,233 in Q4 2016.
  • Tower Research Capital (TRC)'s portfolio value fell 8.5% quarter-over-quarter to $921M.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2016, filed 3 Feb 2017.